Breo(SH:688793) Quan Jing Wang·2026-01-27 12:30Core Viewpoint - The company, Beilingsong (688793.SH), anticipates a net profit attributable to shareholders of between -105 million and -84 million yuan for the fiscal year 2025, primarily due to strategic adjustments and upgrades [1] Financial Performance - The projected net profit for 2025 is expected to be between -105 million and -84 million yuan, indicating a significant loss [1] Strategic Initiatives - Beilingsong is focusing on a "Traditional Chinese Medicine × Technology" core strategy, increasing investment in research and development and model innovation to lay a foundation for long-term high-quality growth [1] - The company has launched the "Early Sleep Doll" IP product series, which has gained over 100 million exposures on social media platforms, showcasing its marketing effectiveness [1] Marketing and Sales - The company initiated a nationwide tour starting in Shenzhen, which has significantly boosted in-store sales, demonstrating the conversion potential of IP-based marketing [1] - Innovative online and offline marketing strategies have highlighted Beilingsong's strong brand building and market influence in the health and personal care sector [1] Service Ecosystem Development - Beilingsong is upgrading its offline service ecosystem with the introduction of the "Relaxation Moment" health management brand, which combines technology product experiences, manual massage, and traditional moxibustion therapy [1] - The company has rapidly established 15 stores in key cities such as Shenzhen, Guangzhou, and Chengdu, and plans to continue its "product + service" dual-driven development path to strengthen its leading position in the health consumption sector [1]